XML 16 R2.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current Assets:    
Cash and cash equivalents $ 106,610 $ 92,642
Restricted cash 235 1,865
Short-term investments 8,021 12,977
Restricted short-term investments 2,200 2,200
Accounts receivable, net 78,090 66,005
Inventories 100,240 96,831
Income tax refunds and deposits 520 385
Prepaid expenses and other assets 7,755 6,777
Total current assets 303,671 279,682
Property, plant, and equipment, net 242,924 260,055
Finance lease right-of-use assets 428 612
Operating lease right-of-use assets 27,663 20,042
Equity method investment 4,193  
Goodwill and intangible assets, net 39,192 40,615
Other assets 11,610 5,250
Deferred tax assets 21,996 24,980
Total assets 651,677 631,236
Current Liabilities:    
Accounts payable and accrued liabilities 88,911 95,504
Income taxes payable 3,960 1,077
Current portion of long-term debt 2,256 12,263
Current portion of operating lease liabilities 2,862 3,357
Total current liabilities 97,989 112,201
Long-term reserve for income tax liabilities 4,709 4,709
Long-term debt, net of current portion and unamortized debt costs 75,552 34,186
Long-term operating lease liabilities, net of current portion 25,466 17,464
Deferred tax liabilities 2,901 741
Other long-term liabilities 14,884 13,212
Total liabilities 221,501 182,513
Stockholders' equity:    
Preferred stock: par value $0.0001; 20,000,000 shares authorized; no shares issued and outstanding
Common stock: par value $0.0001; 300,000,000 shares authorized; 56,051,662 and 47,982,690 shares issued and outstanding as of September 30, 2021 and 54,760,922 and 47,495,439 shares issued and outstanding as of December 31, 2020, respectively 6 5
Additional paid-in capital 412,917 410,061
Retained earnings 160,577 117,773
Accumulated other comprehensive loss (6,277) (3,721)
Treasury stock (137,047) (121,812)
Total Amphastar Pharmaceuticals, Inc. stockholders' equity 430,176 402,306
Non-controlling Interests   46,417
Total equity 430,176 448,723
Total liabilities and stockholders' equity $ 651,677 $ 631,236